Human transscleral albumin permeability and the effect of topographical location and donor age

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 9, 2008, Pages 4041-4045

  Anderson, Owen A ^a   Jackson, Timothy L ^a,b   Singh, Jasmin K ^a   Hussain, Ali A ^a   Marshall, John ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; FLUORESCEIN ISOTHIOCYANATE; ALBUMINOID;

ADULT; AGE; AGED; ANTERIOR EYE CHAMBER ANGLE; ARTICLE; BRAIN REGION; DIFFUSION; DONOR; FEMALE; HUMAN; HUMAN TISSUE; LABELING INDEX; MALE; MOLECULAR WEIGHT; PERMEABILITY; PRIORITY JOURNAL; SCLERA; SPECTROPHOTOMETER; TOPOGRAPHY; AGING; GROWTH, DEVELOPMENT AND AGING; HISTOLOGY; KINETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; REFERENCE VALUE; TEMPERATURE;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALBUMINS; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED; PERMEABILITY; REFERENCE VALUES; SCLERA; TEMPERATURE;

EID: 53149104782     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1660     Document Type: Article

References (26)

1. Rosenfeld PJ, Brown DM, Heier JS, et al.; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419-3121.
2. Brown DM, Kaiser PK, Michels M, et al.; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1432-1444.
3. Amaral J, Fariss RN, Campos MM, et al. Transscleral-RPE permeability of PEDF and ovalbumin proteins: implications for subconjunctival protein delivery. Invest Ophthalmol Vis Sci. 2005;46(12):4383-4392. (Pubitemid 44264530)
4. Cruysberg LP, Franklin AJ, Sanders J, et al. Effective transscleral delivery of two retinal anti-angiogenic molecules: carboxyamidotriazole (CAI) and 2-methoxyestradiol (2ME2). Retina. 2005;25(8):1022-1031. (Pubitemid 44735100)
5. Jackson TL, Hussain A, Hodgetts A, et al. Human scleral hydraulic conductivity: age-related changes, topographical variation, and potential scleral outflow facility. Invest Ophthalmol Vis Sci. 2006;47(11):4942-4946. (Pubitemid 46586397)
6. Kundaiker S, Hussain AA, Marshall J. Component characteristics of the vectorial transport system for taurine in isolated bovine retinal pigment epithelium. J Physiol. 1996;492:505-516. (Pubitemid 26137759)
7. Starita C, Hussain AA, Patmore A, Marshall J. Localization of the site of major resistance to fluid transport in Bruch's membrane. Invest Ophthalmol Vis Sci. 1997;38(3):762-767. (Pubitemid 27143147)
8. Antcliff RJ, Hussain AA, Marshall J. Hydraulic conductivity in fixed retinal tissue after sequential excimer laser ablation. Arch Ophthalmol. 2001;119(4):539-544.
9. Jackson TL, Antcliff RJ, Hillenkamp J, Marshall J. Human retinal molecular weight exclusion limit and estimate of species variation. Invest Ophthalmol Vis Sci. 2003;44(5):2141-2144. (Pubitemid 36520310)
10. Boubriak OA, Urban JP, Akhtar S, Meek KM, Bron AJ. The effect of hydration and matrix composition on solute diffusion in rabbit sclera. Exp Eye Res. 2000;71(5):503-514. (Pubitemid 30947623)
11. Olsen TW, Aaberg SY, Geroski DH, Edelhauser HF. Human sclera: thickness and surface area. Am J Ophthalmol. 1998;125(2):237-241.
12. Burnette RR. Theory of mass transfer. In: Robinson JR, Lee VHL. Controlled Drug Delivery. 2nd ed. Vol.29. New York: Marcel Dekker; 1987:95-138.
13. Olsen TW, Edelhauser HF, Lim JI, Geroski DH. Human scleral permeability. Invest Ophthalmol Vis Sci. 1995;36(9):1893-1903.
14. Simpson AE, Gilbert JA, Rudnick DE, Geroski DH, Aaberg TM Jr, Edelhauser HF. Transscleral diffusion of carboplatin: an in vitro and in vivo study. Arch Ophthalmol. 2002;120(8):1069-1074. (Pubitemid 34856075)
15. Boubriak OA, Urban JP, Bron AJ. Differential effects of aging on transport properties of anterior and posterior human sclera. Exp Eye Res. 2003;76(6):701-713.
16. Watson PG, Young RD. Scleral structure, organisation and disease: a review. Exp Eye Res. 2004;78(3):609-623.
17. Nicholson C, Tao L. Hindered diffusion of high molecular weight compounds in brain extracellular microenvironment measured with integrative optical imaging. Biophys J. 1993;65(6):2277-2290. (Pubitemid 24005961)
18. Ambati J, Canakis CS, Miller JW, et al. Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci. 2000;41(5):1181- 1185. (Pubitemid 30187558)
19. Foster CS, Sainz de la Maza M. The Sclera. New York: Springer-Verlag; 1994.
20. Edwards A, Prausnitz MR. Fiber matrix model of sclera and corneal stroma for drug delivery to the eye. Am Inst Chem Eng J. 1998;44:214-225. (Pubitemid 128485306)
21. Malik NS, Moss SJ, Ahmed N, Furth AJ, Wall RS, Meek KM. Ageing of the human corneal stroma: structural and biochemical changes. Biochim Biophys Acta. 1992;1138(3):222-228.
22. Malik NS, Meek KM. The inhibition of sugar-induced structural alterations in collagen by aspirin and other compounds. Biochem Biophys Res Commun. 1994;199(2):683-686.
23. Brown CT, Vural M, Johnson M, Trinkaus-Randall V. Age-related changes of scleral hydration and sulfated glycosaminoglycans. Mech Ageing Dev. 1994;77(2):97-107.
24. Rada JA, Achen VA, Penugonda S, et al. Proteoglycan composition in the human sclera during growth and aging. Invest Ophthalmol Vis Sci. 2000;41(7):1639-1648. (Pubitemid 30354331)
25. Pallikaris IG, Kymionis GD, Ginis HS, Kounis A, Tsilimbaris MK. Ocular rigidity in living human eyes. Invest Ophthalmol Vis Sci. 2005;45:409-414.
26. Curtin BJ. Physiopathologic aspects of scleral stress-strain. Trans Am Ophthalmol Soc. 1969;67:417-461.